retatrutide glp-1 Retatrutide, a GIP, and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Retatrutide for Weight Loss: What

This includes fruits, vegetables, lean proteins, and whole grains

Tirzepatide, also known as Zepbound, is gaining attention as a powerful option

For example, Ozempic is covered only to treat diabetes, and Wegovy is covered for the indication of Major Adverse Cardiovascular Events (MACE) reduction in overweight/obese adults, but neither are currently covered for obesity as a standalone condition

During follow-up, 915 MACE events occurred

Ongoing monitoring of kidney function and overall health is critical to ensure the treatment remains both safe and effective

GLP-1 medications can be genuinely helpful during this transition, but the perimenopause hormonal fluctuations mean thyroid levels may need even more frequent monitoring